Also trades as: SNBIF (OTC) · $vol 0M
4592.T JPX
SanBio Company Limited
1W: -1.1%
1M: -3.0%
3M: -5.7%
YTD: -52.2%
1Y: -64.5%
3Y: +57.1%
5Y: -34.2%
¥944.00 ($5.98)
+3.00 (+0.32%)
Weekly Expected Move ±6.5%
¥819
¥880
¥941
¥1002
¥1063
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
-$8M
+14.0% ▲
Operating Income
-$3.8B
-7.9% ▼
Net Income
-$3.8B
-33.3% ▼
EPS (Diluted)
$-52.55
-25.5% ▼
EBITDA
-$4.2B
-40.9% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $132M | $25M | $15M | $9M | $8M |
| Gross Profit | -$132M | -$25M | -$15M | -$9M | -$8M |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $5.0B | $6.1B | $2.8B | $2.4B | $2.7B |
| SG&A Expenses | $1.7B | $1.8B | $1.7B | $1.1B | $1.1B |
| Operating Expenses | $6.6B | $7.9B | $4.5B | $3.5B | $3.8B |
| Operating Income | -$6.6B | -$7.9B | -$4.5B | -$3.5B | -$3.8B |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $45M | $25M | $26M | $19M | $81M |
| Income Before Tax | -$4.6B | -$4.7B | -$2.5B | -$3.0B | -$4.3B |
| Tax Expense | $117M | $862M | $102M | -$128M | -$449M |
| Net Income | -$4.7B | -$5.6B | -$2.6B | -$2.9B | -$3.8B |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-90.33 | $-95.99 | $-40.48 | $-41.86 | $-52.55 |
| EBITDA | -$4.4B | -$4.6B | -$4.5B | -$3.5B | -$4.2B |
| Shares Outstanding | 52M | 58M | 65M | 69M | 73M |